Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1032 results for "fda"

STAT Plus: FDA pushes back against shortcuts in product testing

FDA told to pull out Colistin anti-biotic from drug shelves

The Public Health Ministry is to propose the Food and Drugs Administration to remove oral Colistin anti-biotic drug from drug shelves to put a stop to widespread abuses of the drug which may lead to bacterial resistant to the drug. Public Health ... Thai Public Broadcasting Service, 7 hours ago

5,422 images for fda

PharmaVOICE, 4 hours ago
FiercePharma, 9 hours ago, 7 hours ago
Gizmodo India, 6 hours ago
News, 5 hours ago, 13 hours ago
Boston Globe, 6 hours ago
Northern Public Radio, 10 hours ago
ODT Mag, 1 day ago
ODT Mag, 1 day ago
Counsel & Heal

US FDA approves AbbVie's Imbruvica to treat marginal zone lymphoma

The US Food and Drug Administration (FDA) has approved AbbVie's Imbruvica (ibrutinib) for the treatment of patients with relapsed / refractory (R/R) marginal zone lymphoma (MZL). The indication is approved under accelerated approval, which is ...
 Pharmaceutical Technology1 day ago Ibrutinib, First FDA-Approved Therapy for Marginal Zone Lymphoma  ESMO1 day ago FDA Approves Imbruvica for the Treatment of Marginal Zone Lymphoma in Some Patients  Pharmacy Times57 minutes ago Marginal Zone Lymphona: FDA Approves First Drug For This Rare Form Of Non-Hodgkin's Lymphoma  Counsel & Heal3 days ago

FDA Approves Perrigo's AB Rated Generic Version Of Topicort® Spray, 0.25%

 American Pharmaceutical Review7 hours ago PERRIGO : Announces FDA Approval Of Its First-To-File AB Rated Generic Version Of Topicort┬« Spray, 0.25%  4 Traders8 hours ago Perrigo Announces FDA Approval Of Its First-To-File AB Rated Generic Version Of Topicort┬« Spray, 0.25%  Yahoo! Finance7 hours ago BRIEF-Perrigo announces FDA approval of its first-to-file ab rated generic version of Topicort spray  Reuters UK8 hours ago

Next-Generation Blood Test for Latent TB Submitted to FDA

Image: The QuantiFERON-TB Gold Plus blood test for TB (Photo courtesy of QIAGEN). QuantiFERON-TB Gold Plus, launched in 2016 in over 60 countries worldwide and used to test for tuberculosis (TB) infection in over 600,000 people to date, has now ...
 Lab Medica24 minutes ago

Jazz Pharma eases off intraday high, Erwinaze supplier target of FDA Warning Letter

Jazz Pharmaceuticals ( JAZZ -0.6%) turns from green to red in late trading on the news that Erwinaze supplier Porton Biopharma received a Warning Letter from the FDA regarding cGMP violations noted during an on-site inspection. The Salisbury, ...
 Seeking Alpha53 minutes ago FDA's Approval of Generic Version of Jazz Pharma's Sleep Disorder Drug Raises Questions  Pharmacy Choice12 hours ago FDA Urges Sponsors to Minimize Design Changes in Generic Drug Delivery Products  FDA News1 day ago FDA approves generic version of Jazz Pharma's sleep disorder drug  Reuters6 days ago
Medical Device Network

OssDsign receive US FDA marketing approval for medical implant, OssDsign Cranial

OssDsign AB, a Swedish designer, manufacturer and distributor of next generation implants for Cranial and facial reconstruction, has received 510(k) clearance by the US FDA for marketing and sale of OssDsign Cranial PSI in the USA. Anders ...
 PharmaBiz1 day ago OssDsign annunces FDA clearance  Nordic Life Science15 hours ago OssDsign secures FDA 510(k) clearance for Cranial PSI Jan 23  Medical Device Network1 day ago Ossdsign Cranial patient-specific medical implant wins FDA 510(k) clearance  Medical Devices Business Review1 day ago

BIOLASE launches its FDA cleared Epic Pro Diode Laser System worldwide; shares ahead 18% premarket

BIOLASE (NASDAQ: BIOL ) announces the worldwide launch of its Epic Pro laser system, a diode laser systemthat offers higher laser power than most diode lasers in dentistry. The Epic Pro is the first commercially available laser system resulting ...
 Seeking Alpha1 day ago FDA Awards Biolase Marketing Clearance for Epic Pro Diode Laser System  FDA News22 hours ago BIOLASE Inc. Snags FDA Nod and Worldwide Launch of Its New Epic Pro Diode Laser System  BioSpace1 day ago BIOLASE Announces the FDA Clearance and Worldwide Launch of Its New Epic Pro Diode Laser System  Minyanville1 day ago
Medical Marketing And Media

FDA announces draft guidance to help sprout operations maintain safety

The U.S. Food and Drug Administration (FDA) has issued for public comment a draft guidance to help sprout operations meet new standards designed to help keep sprouts free of contamination and safe for consumers to eat. Sprout operations have new ...
 Institute of Food Technologists3 hours ago FDA guidance seeks to clarify pharma comms with payers  Medical Marketing And Media3 hours ago FDA Issues Final Guidance on Benefit-Risk Factors to Consider in Medical Device Product Availability, Compliance, and Enforcement Decisions  JD Supra19 hours ago FDA Recommends Switching Studies to Demonstrate Biosimilar Interchangeability  FDA News22 hours ago

Biolase laser receives FDA clearance

By DrBicuspid Staff January 24, 2017 -- Laser and CAD/CAM scanner company Biolase has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Epic Pro laser system. The Epic Pro is a dental diode laser system. The laser can ...
 DrBicuspid.com1 hour ago FDA grants clearance to Biolase  International Business Times21 hours ago AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug  Pettinga Financial Advisors1 day ago BD wins expanded FDA 510(k) clearance for PleurX cath system  MassDevice1 day ago
Channel NewsAsia

Tocilizumab Gets FDA Priority Review for Giant Cell Arteritis

The US Food and Drug Administration (FDA) has accepted Genentech's Supplemental Biologics License Application (sBLA) and granted priority for tocilizumab (Actemra/Genentech) to treat adults with giant cell arteritis (GCA) a form of vasculitis. ...
 HCPLive4 hours ago Actemra Achieves Positive Trial Results As Giant Cell Arteritis Treatment, Receives Priority Review Designation From FDA  Tech Times6 hours ago Roche's Actemra granted Priority Review by FDA  Pharmafile7 hours ago Roche : FDA grants priority review for Roche's Actemra/RoActemra (tocilizumab) supplemental biologics license application for giant cell arteritis, a form of vasculitis  4 Traders15 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less